📰 Generate Life Sciences News
Page 2 - Generate Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Generate Life Sciences. Real-time updates on events, politics, business and more.
January 24, 2022
San Ramon-based medical device firm CooperCompanies recently signed a definitive purchase agreement to acquire reproductive sciences company Generate Life Sciences for $1.6 billion in a deal.
November 4, 2021
Noida, Nov. 04, 2021 (GLOBE NEWSWIRE) -- An increasing number of infertility issues among men and women resulting from unhealthy lifestyles is driving...
October 21, 2021
/PRNewswire/ -- Generate Life Sciences recently presented data from its research programs during this years American Society for Reproductive Medicine (ASRM)...
October 13, 2021
/PRNewswire/ -- Generate Life Sciences today announced it is donating a Sepax 2 S-100 cell bioprocessing system manufactured by Cytiva to Rutgers Cancer...
October 13, 2021
/PRNewswire/ -- Generate Life Sciences today announced it is donating a Sepax 2 S-100 cell bioprocessing system manufactured by Cytiva to Rutgers Cancer...
June 7, 2021
Australian middle-market PE firm CPE has agreed to sell Cell Care Group, its cord blood banking business, to Generate Life Sciences.
June 3, 2021
The acquisition provides the companies with shared scientific knowledge and resources leading to a stronger foundation for advancing newborn stem...
June 2, 2021
The Cell Care international umbilical cord blood and tissue banking group, which incorporates Insception Biosciences Inc. (Insception) in Canada, today announced that it has been acquired by Generate Life Sciences (Generate).* Generate operates Cord Blood Registry (CBR), North America's largest cord blood bank and one of the world's preeminent stem cell R&D organizations. Insception joins CBR to create a unique, international scientific collaboration to further newborn stem cell a...
June 2, 2021
/PRNewswire/ -- Generate Life Sciences (Generate) today announced that it has acquired the Cell Care international cord blood banking group (Cell Care), which...
May 19, 2021
Share this article SAN FRANCISCO, May 19, 2021 /PRNewswire/ -- The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been accl...